UFP TECHNOLOGIES INC (UFPT)

US9026731029 - Common Stock

304.79  +6 (+2.01%)

After market: 304.79 0 (0%)

Fundamental Rating

6

Taking everything into account, UFPT scores 6 out of 10 in our fundamental rating. UFPT was compared to 188 industry peers in the Health Care Equipment & Supplies industry. UFPT gets an excellent profitability rating and is at the same time showing great financial health properties. UFPT is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make UFPT suitable for growth and quality investing!



8

1. Profitability

1.1 Basic Checks

In the past year UFPT was profitable.
In the past year UFPT had a positive cash flow from operations.
UFPT had positive earnings in each of the past 5 years.
Each year in the past 5 years UFPT had a positive operating cash flow.

1.2 Ratios

UFPT has a Return On Assets of 11.73%. This is amongst the best in the industry. UFPT outperforms 93.58% of its industry peers.
UFPT has a Return On Equity of 15.98%. This is amongst the best in the industry. UFPT outperforms 92.51% of its industry peers.
UFPT has a Return On Invested Capital of 13.74%. This is amongst the best in the industry. UFPT outperforms 95.72% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for UFPT is in line with the industry average of 8.23%.
The 3 year average ROIC (9.40%) for UFPT is below the current ROIC(13.74%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.73%
ROE 15.98%
ROIC 13.74%
ROA(3y)8.98%
ROA(5y)8.8%
ROE(3y)13.83%
ROE(5y)12.26%
ROIC(3y)9.4%
ROIC(5y)9.46%

1.3 Margins

With an excellent Profit Margin value of 11.87%, UFPT belongs to the best of the industry, outperforming 88.24% of the companies in the same industry.
UFPT's Profit Margin has improved in the last couple of years.
UFPT has a better Operating Margin (14.99%) than 85.56% of its industry peers.
UFPT's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 28.04%, UFPT is doing worse than 75.94% of the companies in the same industry.
UFPT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.99%
PM (TTM) 11.87%
GM 28.04%
OM growth 3Y14.65%
OM growth 5Y5.97%
PM growth 3Y14.56%
PM growth 5Y8.39%
GM growth 3Y4.03%
GM growth 5Y2%

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UFPT is creating some value.
UFPT has more shares outstanding than it did 1 year ago.
UFPT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for UFPT has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 14.95 indicates that UFPT is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 14.95, UFPT belongs to the top of the industry, outperforming 89.84% of the companies in the same industry.
The Debt to FCF ratio of UFPT is 0.82, which is an excellent value as it means it would take UFPT, only 0.82 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of UFPT (0.82) is better than 90.37% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that UFPT is not too dependend on debt financing.
The Debt to Equity ratio of UFPT (0.11) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 0.82
Altman-Z 14.95
ROIC/WACC1.53
WACC9%

2.3 Liquidity

UFPT has a Current Ratio of 3.13. This indicates that UFPT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.13, UFPT is in line with its industry, outperforming 54.55% of the companies in the same industry.
UFPT has a Quick Ratio of 1.63. This is a normal value and indicates that UFPT is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.63, UFPT perfoms like the industry average, outperforming 42.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.13
Quick Ratio 1.63

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 28.86% over the past year.
Measured over the past years, UFPT shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.74% on average per year.
The Revenue has grown by 18.48% in the past year. This is quite good.
UFPT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.00% yearly.
EPS 1Y (TTM)28.86%
EPS 3Y48.68%
EPS 5Y22.74%
EPS Q2Q%38.82%
Revenue 1Y (TTM)18.48%
Revenue growth 3Y30.65%
Revenue growth 5Y16%
Sales Q2Q%44.01%

3.2 Future

UFPT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.51% yearly.
Based on estimates for the next years, UFPT will show a quite strong growth in Revenue. The Revenue will grow by 17.92% on average per year.
EPS Next Y29.29%
EPS Next 2Y22.29%
EPS Next 3Y19.51%
EPS Next 5YN/A
Revenue Next Year28.04%
Revenue Next 2Y23.02%
Revenue Next 3Y17.92%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 43.48, UFPT can be considered very expensive at the moment.
Based on the Price/Earnings ratio, UFPT is valued a bit cheaper than 69.52% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.96, UFPT is valued quite expensively.
Based on the Price/Forward Earnings ratio of 34.84, the valuation of UFPT can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UFPT indicates a somewhat cheap valuation: UFPT is cheaper than 73.26% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.82. UFPT is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 43.48
Fwd PE 34.84

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, UFPT is valued a bit cheaper than 72.19% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, UFPT is valued a bit cheaper than 75.94% of the companies in the same industry.
Industry RankSector Rank
P/FCF 54.29
EV/EBITDA 31.04

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
UFPT has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as UFPT's earnings are expected to grow with 19.51% in the coming years.
PEG (NY)1.48
PEG (5Y)1.91
EPS Next 2Y22.29%
EPS Next 3Y19.51%

0

5. Dividend

5.1 Amount

No dividends for UFPT!.
Industry RankSector Rank
Dividend Yield N/A

UFP TECHNOLOGIES INC

NASDAQ:UFPT (11/21/2024, 8:00:01 PM)

After market: 304.79 0 (0%)

304.79

+6 (+2.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.34B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 43.48
Fwd PE 34.84
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.48
PEG (5Y)1.91
Profitability
Industry RankSector Rank
ROA 11.73%
ROE 15.98%
ROCE
ROIC
ROICexc
ROICexgc
OM 14.99%
PM (TTM) 11.87%
GM 28.04%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.13
Quick Ratio 1.63
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)28.86%
EPS 3Y48.68%
EPS 5Y
EPS Q2Q%
EPS Next Y29.29%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)18.48%
Revenue growth 3Y30.65%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y